Key result
POLARx FIT linked to ~8% lower procedural costs vs Arctic Front Advance Pro.
Why the study?
Does the POLARx FIT cryoballoon ablation system reduce procedural costs and time compared to the Arctic Front Advance Pro system in patients with paroxysmal atrial fibrillation?
Cohort (n=80)
No
Does the POLARx FIT cryoballoon ablation system reduce procedural costs and time compared to the Arctic Front Advance Pro system in patients with paroxysmal atrial fibrillation?
The POLARx FIT cryoballoon system reduces procedural time and associated hospital costs compared to the Arctic Front Advance Pro system for paroxysmal AF ablation, with a similar safety profile.
Answers are grounded in this paper and cite their sources.
May support cost savings in paroxysmal AF ablation; leaves open confirmation in randomized trials.
Background Pulmonary vein isolation (PVI) is the main ablation strategy for the treatment of paroxysmal atrial fibrillation. Different technologies are available for PVI, including various cryoballoon catheters (CB-A). Compared with the Arctic Front Advance Pro™, the novel POLARx FIT™ CB-A might reduce costs for atrial fibrillation ablation. Objective The aim of this study is to perform a health economic evaluation of two cryoballoon systems for PVI procedures. Methods All patients undergoing their first PVI procedure with POLARx FIT™ CB-A or the Arctic Front Advance Pro™ CB-A were prospectively enrolled. The health economic analysis was performed on the index hospitalization and procedure. The primary safety endpoint included procedure-related adverse events within the index hospitalization. A decision tree model was built to estimate downstream costs. Results A total of 80 patients with paroxysmal atrial fibrillation undergoing PVI were analyzed, with 40 patients in each arm. Compared with the Arctic Front Advance Pro™ CB-A, POLARx FIT™ CB-A showed a lower procedure time, left-atrium dwell time, and fluoroscopy time. The complication rate was low (6.3%) and included 3 reversible phrenic nerve palsies in the POLARx FIT™ CB-A group vs 2 in the Arctic Front Advance Pro™ CB-A group. Compared with the Arctic Front Advance Pro, the POLARx FIT™ CB-A was associated with lower procedural costs (€2069.7 ± €165.2 vs €2239.5 ± €366.0; P =.009). Conclusion The POLARx FIT™ CB-A was associated with a shorter procedure time, translating into lower procedural costs, compared with the Arctic Front Advance Pro. Complications were rare and comparable between the two technologies.
No takes yet. Share an insight, caveat, or question.
Pannone et al. (2025) conducted a cohort in Paroxysmal atrial fibrillation (n=80). POLARx FIT™ cryoballoon ablation vs. Arctic Front Advance Pro™ cryoballoon ablation was evaluated on Procedural costs (excluding materials) (p=0.009). The POLARx FIT cryoballoon ablation system was associated with lower procedural costs compared with the Arctic Front Advance Pro, driven by shorter procedure times.
Synapse has enriched 10 related papers. Consider them for comparative context: